1. |
孙立峰, 丁凌, 范钰, 等. 结直肠肿瘤肝转移基础研究概况[J]. 实用肿瘤杂志, 2007, 22(3):198-200.
|
2. |
屈伸, 刘志国. 分子生物学实验技术[M]. 北京:化学工业出版社, 2007:364-398.
|
3. |
邢戌健, 贾户亮, 张磊, 等. 基因芯片技术在肝细胞癌候选诊断指标筛选中的应用[J]. 中国普外基础与临床杂志, 2007, 14(1):23-27.
|
4. |
张红, 楚胜华, 冯东福, 等. 应用基因芯片筛选不同胶质瘤细胞相关基因[J]. 中华实验外科杂志, 2012, 29(2):253-255.
|
5. |
Boltze C. Loss of maspin is a helpful prognosticator in colorectal cancer:a tissue microarray analysis[J]. Pathol Res Pract, 2005, 200(11-12):783-790.
|
6. |
文坤明, 曾庆良, 冯国丽, 等. 结直肠癌患者淋巴结微转移与其免疫功能的关系[J]. 中国普外基础与临床杂志, 2009, 16(11):890-894.
|
7. |
Ge W, Hu H, Zheng S. High osteopontin and low SPARC-like 1 co-expression in colorectal liver metastasis were identified by integrated analysis of cytoband and microarray[C]. American Association for Cancer Research Annual Meeting:Proceedings. 2007 Apr 14-18;Los Angeles, CA. Philadelphia (PA):AACR;2007. Abstract nr 4701.
|
8. |
丁友成, 张辉, 钟明安, 等. 基因芯片技术筛选大肠癌肝转移差异表达基因[J]. 南京医科大学学报(自然科学版), 2008, 28(4):476-479.
|
9. |
Le GT, Abbenante G, Fairlie DP. Profiling the enzymatic properties and inhibition of human complement factor B[J]. J Biol Chem, 2007, 282(48):34809-34816.
|
10. |
Yio XY, Mayer L. Characterization of a 180-kDa intestinalepithelial cell membrane glycoprotein, gp180. A candidate molecule mediating t cell-epithelial cell interactions[J]. J Biol Chem, 1997, 272(19):12786-12792.
|
11. |
孙仁山, 陈晓红, 冉新泽, 等. 高亲和力IgE受体介导的信号传导及其相关的抑制性受体[J]. 中国药理学通报, 2005, 21(4):385-389.
|
12. |
Wu J, Edberg JC, Redecha PB, et al. A novel polymorphism of Fc gamma RⅢa (CD16) alters receptor function and predisposes to autoimmune disease[J]. J Clin Invest, 1997, 100(5):1059-1070.
|
13. |
Zhang W, Gordon M, Schultheis AM, et al. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab[J]. J Clin Oncol, 2007, 25(24):3712-3718.
|
14. |
Senga T, Iwamoto S, Yoshida T, et al. LSSIG is a novel murineleukocyte-specific GPCR that is induced by the activation of STAT3[J]. Blood, 2003, 101(3):1185-1187.
|
15. |
Nilsson NE, Kotarsky K, Owman C, et al. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids[J]. Biochem Biophys Res Commun, 2003, 303(4):1047-1052.
|
16. |
Karaki S, Tazoe H, Hayashi H, et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon[J]. J Mol Histol, 2008, 39(2):135-142.
|
17. |
Tang Y, Chen Y, Jiang H, et al. G-protein-coupled receptor for short-chain fatty acids suppresses colon Cancer[J]. Int J Cancer,.
|
18. |
Pashine A, Busch R, Belmares MP, et al. Interaction of HLA-DRwith an acidic face of HLA-DM disrupts sequence-dependentinteractions with peptides[J]. Immunity, 2003, 19(2):183-192.
|
19. |
Brocke P, Garbi N, Momburg F, et al. HLA-DM, HLA-DO and tapasin:functional similarities and differences[J]. Curr Opin Immunol, 2002, 14(1):22-29.
|
20. |
Callahan MJ, Nagymanyoki Z, Bonome T, et al. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer[J]. Clin Cancer Res, 2008, 14(23):7667-7673.
|
21. |
Seung S, Urban JL, Schreiber H. A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+T cells to an antigen that no longer serves as a target[J]. J Exp Med, 1993, 178(3):933-940.
|
22. |
Arboleda MJ, Lyons JF, Kabbinavar FF, et al. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1integrins, increased invasion, and metastasis of human breast and ovarian cancer cells[J]. Cancer Res, 2003, 63(1):196-206.
|
23. |
Zhu JW, Brdicka T, Katsumoto TR, et al. Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling[J]. Immunity, 2008, 28(2):183-196.
|
24. |
Penninger JM, Irie-Sasaki J, Sasaki T, et al. CD45:new jobs for an old acquaintance[J]. Nat Immunol, 2001, 2(5):389-396.
|
25. |
, 128(4):847-856.
|